We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$26.1B
AUM Growth
+$1.03B
Cap. Flow
-$146M
Cap. Flow %
-0.56%
Top 10 Hldgs %
13.61%
Holding
1,470
New
112
Increased
493
Reduced
531
Closed
130

Top Buys

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$94.2M
2
MDT icon
Medtronic
MDT
+$83.5M
3
VZ icon
Verizon
VZ
+$54.1M
4
ADBE icon
Adobe
ADBE
+$54.1M
5
AMZN icon
Amazon
AMZN
+$50.7M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$81.3M
2
ST icon
Sensata Technologies
ST
+$78M
3
PCG icon
PG&E
PCG
+$52M
4
AMGN icon
Amgen
AMGN
+$43.5M
5
LOW icon
Lowe's Companies
LOW
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 22.67%
2 Healthcare 15.83%
3 Consumer Discretionary 11.21%
4 Financials 11.2%
5 Industrials 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STML
526
DELISTED
Stemline Therapeutics, Inc.
STML
$7.25M 0.03%
451,988
-112,516
-20% -$2.01M
IDXX icon
527
Idexx Laboratories
IDXX
$40.2B
$7.25M 0.03%
33,271
-6,523
-16% -$1.34M
VEEV icon
528
Veeva Systems
VEEV
$43.2B
$7.19M 0.03%
93,493
-28
-0% -$2.13K
INGR icon
529
Ingredion
INGR
$6.25B
$7.16M 0.03%
64,668
-55,345
-46% -$6.51M
ATO icon
530
Atmos Energy
ATO
$27.4B
$7.16M 0.03%
79,383
+71,550
+913% +$6.19M
MTZ icon
531
MasTec
MTZ
$17.9B
$7.15M 0.03%
140,895
+17,550
+14% +$848K
DFS
532
DELISTED
Discover Financial Services
DFS
$7.11M 0.03%
101,037
+7,352
+8% +$539K
BFAM icon
533
Bright Horizons
BFAM
$3.28B
$7.11M 0.03%
69,344
+20,340
+42% +$2.04M
OXM icon
534
Oxford Industries
OXM
$444M
$7.09M 0.03%
85,500
+5,100
+6% +$411K
PENN icon
535
PENN Entertainment
PENN
$2.38B
$7.02M 0.03%
209,000
-124,300
-37% -$3.88M
WD icon
536
Walker & Dunlop
WD
$1.38B
$7.01M 0.03%
125,900
-7,000
-5% -$404K
WDR
537
DELISTED
Waddell & Reed Financial, Inc.
WDR
$7M 0.03%
389,300
FXI icon
538
iShares China Large-Cap ETF
FXI
$4.1B
$6.95M 0.03%
161,615
CMS icon
539
CMS Energy
CMS
$20.7B
$6.94M 0.03%
146,698
-170
-0.1% -$7.68K
SRC
540
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$6.93M 0.03%
172,707
-62,313
-27% -$2.37M
CRZO
541
DELISTED
Carrizo Oil & Gas Inc
CRZO
$6.9M 0.03%
247,600
+102,000
+70% +$2.35M
LOGM
542
DELISTED
LogMein, Inc.
LOGM
$6.88M 0.03%
66,597
-164,300
-71% -$18.4M
BLKB icon
543
Blackbaud
BLKB
$2.05B
$6.83M 0.03%
66,710
+15,318
+30% +$1.58M
SABR icon
544
Sabre
SABR
$843M
$6.82M 0.03%
276,762
+51,500
+23% +$1.19M
LVS icon
545
Las Vegas Sands
LVS
$26.7B
$6.81M 0.03%
89,210
+11,091
+14% +$847K
CC icon
546
Chemours
CC
$2.21B
$6.81M 0.03%
153,492
-85,521
-36% -$4.25M
WDC icon
547
Western Digital
WDC
$149B
$6.81M 0.03%
116,346
+88,511
+318% +$5.63M
CAL icon
548
Caleres
CAL
$425M
$6.78M 0.03%
197,121
+3,800
+2% +$131K
ORBK
549
DELISTED
Orbotech Ltd
ORBK
$6.76M 0.03%
109,442
-21,378
-16% -$1.32M
OEF icon
550
iShares S&P 100 ETF
OEF
$20.1B
$6.75M 0.03%
56,402
-3,000
-5% -$357K

Similar funds

Axa's Q2 2018 Portfolio in Review

As of Q2 2018, Axa held 1,470 positions worth $26.1B, up 4.1% from $25.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2018 filing shows 112 new, 493 increased, 531 reduced and 130 closed positions. Its largest new stake was Foot Locker: 289,100 shares worth $15.2M. The largest sale was AbbVie, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2018 buy was Foot Locker: 289,100 shares worth $15.2M.
  • Axa added most to TE Connectivity in Q2 2018, an estimated $94.2M increase.
  • Axa's biggest Q2 2018 reduction was AbbVie, cutting an estimated $81.3M.
  • Axa fully exited PG&E in Q2 2018, selling an estimated $52M.
  • Axa's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2018.
  • Axa opened 112 new positions and closed 130 in Q2 2018.
  • Axa's portfolio value rose 4.1% quarter-over-quarter to $26.1B.

Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.